Starwood Property Trust, Inc. (STWD)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,335	6,389	6,584	5,675	7,461	5,494
Market Cap Growth	13.84%	-2.96%	16.02%	-23.94%	35.78%	-21.61%
PE Ratio	18.29	18.11	19.78	6.64	16.92	16.83
PS Ratio	19.27	15.94	17.79	9.14	10.40	8.16
PB Ratio	1.06	0.89	0.94	0.79	1.12	1.13
P/FCF Ratio	11.06	10.33	13.08	30.10	-	5.39
P/OCF Ratio	10.61	9.88	12.46	26.55	-	5.26
Debt / Equity Ratio	2.75	2.43	2.79	2.86	2.56	2.64
Debt / FCF Ratio	29.84	28.24	38.97	109.27	-	12.59
Quick Ratio	11.82	17.56	15.33	16.86	38.43	28.12
Current Ratio	13.57	20.49	17.93	19.45	45.63	31.01
Asset Turnover	0.01	0.01	0.01	0.01	0.01	0.01
Return on Equity (ROE)	5.57%	5.35%	5.88%	15.30%	8.55%	7.32%
Return on Assets (ROA)	0.62%	0.58%	0.56%	1.30%	0.60%	0.46%
Earnings Yield	4.96%	5.63%	5.15%	15.36%	6.00%	6.04%
Earnings Yield	4.96%	5.63%	5.15%	15.36%	6.00%	6.04%
FCF Yield	9.04%	9.68%	7.65%	3.32%	-13.62%	18.57%
Dividend Yield	9.61%	10.63%	10.57%	13.40%	11.08%	15.05%
Payout Ratio	175.85%	172.25%	177.23%	67.87%	123.72%	164.88%
Buyback Yield / Dilution	-6.36%	-3.24%	1.65%	-6.37%	-5.08%	2.50%
Total Shareholder Return	3.28%	7.39%	12.23%	7.03%	6.00%	17.54%

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.

SEC Filings: 10-K · 10-Q